Opinion

Video

Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

The panel continues its review of data presented on MRD testing in colorectal cancer from the INTERCEPT and COSMOS-CRC-01 studies.

Related Videos
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Massimo Cristofanilli, MD, attending physician, NewYork-Presbyterian Hospital; professor, medicine, Weill Cornell Medical College, Cornell University
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Joseph M. Scandura, MD, PhD, Weill Cornell
Benjamin Adam Weinberg, MD, associate professor, medicine, Georgetown Lombardi Comprehensive Cancer Center